Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNK2 | Q07912 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.36 |
| ▸ | ACP1 | P24666 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5897 | 0.95 | TNK2 (0.40) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL16055037 | 0.88 | HSD11B1 (0.41) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL17307389 | 0.86 | TNK2 (0.36) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL15512365 | 0.86 | TNK2 (0.36) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL3500438 | 0.86 | TNK2 (0.44) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL14184919 | 0.85 | NPY1R (0.38) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL217929 | 0.84 | TNK2 (0.43) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL15871182 | 0.84 | TNK2 (0.43) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL3109276 | 0.83 | TNK2 (0.46) | TNK2HSD11B1MEN1KMT2ADHFR | |
| SCHEMBL17307392 | 0.82 | MEN1 (0.35) | TNK2HSD11B1MEN1KMT2ADHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150340627-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-20150340627-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-7351452-B2 | Liquid crystalline compounds containing a biphenyl core | QINETIQ LIMITED (GB) | 2008-04-01 | — | — | US | disclosed |
| WO-2003040074-A1 | LIQUID CRYSTALLINE COMPOUNDS CONTAINING A BIPHENYL CORE | QINETIQ LIMITED (GB) | 2003-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150340627-A1 | MATERIALS FOR ELECTRONIC DEVICES | ESR1, EPX, SDHB | TNK2 3552/4885HSD11B1 2745/4885MEN1 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.